/Companies

Ceribell

NASDAQ: CBLL

Sunnyvale, US · Delaware corporation · 5 known investors

Find your way into Ceribell

Sign up to see every warm intro you have to Ceribell

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ceribell team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.

Founders & leadership

JPJosef Parvizi
Josef ParviziCo-FounderJosef Parvizi is a neurologist with clinical experience treating seizure disorders who has worked on the development of medical devices and procedures for neurodiagnostic care.
X(Xingjuan (Jane) Chao
Xingjuan (Jane) ChaoPresident, CEO, Co-Founder & Director
SBScott Blumberg
Scott BlumbergChief Financial Officer
JT
Joseph TaylorNamed on SEC filing
RW
Raymond WooNamed on SEC filing
DS
David StoffelNamed on SEC filing
WB
William BurkeNamed on SEC filing
RR
Rebecca RobertsonNamed on SEC filing
DR
Dan RogyNamed on SEC filing

Board

LI
Lucian IancoviciBoard director
JT
Julie Tammenoms BakkerBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$102.5M disclosed across 1 round · 2021

▶$102.5MraisedSep 2022 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph TaylorDirector
  • Scott BlumbergExecutive Officer
  • Lucian IancoviciDirector
  • Raymond WooExecutive Officer
  • Josef ParviziDirector
  • David StoffelExecutive Officer
  • Xingjuan ChaoExecutive Officer, Director
  • William BurkeDirector
  • Julie Tammenoms BakkerDirector
  • Rebecca RobertsonDirector
  • Dan RogyExecutive Officer
Offering amount
$102.5M
Amount sold
$102.5M
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$578.3Mvaluation at IPOOct 2024 · $17.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Related companies · 3

Companies working in the same space as Ceribell.

In the news

Frequently asked questions

What does Ceribell do?
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.
Who founded Ceribell?
Ceribell was founded by Josef Parvizi, Xingjuan (Jane) Chao.
Who are Ceribell's investors?
Ceribell's investors include Longitude Capital, RA Capital, Red Tree Venture, ShangBay Capital LLC, The Rise Fund.
How much funding has Ceribell raised?
Ceribell has disclosed $102.5M raised across 1 round.
Where is Ceribell headquartered?
Ceribell is headquartered in Sunnyvale, US.